Lumonus’ Post

In patients with high-risk #MIBC, the 2-year locoregional failure-free survival rate was 87.1% with radiotherapy and 76.0% with observation. From Cancer Therapy Advisor. https://bit.ly/499ZqtR #blcsm #bladdercancer

𝐁𝐫𝐚𝐜𝐡𝐲𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭, 𝟐𝟎𝟐𝟏 - 𝟐𝟎𝟐𝟖 The Brachytherapy Market focuses on internal radiation therapy used to treat various cancers by placing radioactive sources close to or inside the tumor. It offers high precision, minimal side effects, and shorter treatment times compared to external radiation. #BrachytherapyMarket #CancerTreatment #RadiationTherapy #Oncology #HealthcareTechnology #MedicalDevices #PrecisionMedicine #CancerCare #HealthcareInnovation #MarketTrends 𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://lnkd.in/dEdSZUET

Aster Whitefield Sets National Benchmark With 140+ IOeRT Cancer Procedures Aster Whitefield becomes India’s first hospital to complete over 140 Intraoperative Electron Radiation Therapy (IOeRT) procedures, redefining precision, safety, and recovery in cancer care Read more: https://lnkd.in/gGFehswQ Dr. Somashekhar S P | Dr. M S Belliappa #AsterWhitefield #IOeRT #CancerCare #OncologyInnovation #PrecisionRadiotherapy Annurag Batra | BW Businessworld | Harbinder Narula | Tanvie Ahuja | Kavi Singh Bhandari | Arya Rakshita

An insightful article about the latest advancements in radiotherapy at GenesisCare UK. 🌟 Dr Peter Dickinson shared exciting news at ASTRO 2025 about adding the first Elekta Unity MR Linac to their fleet in Leeds. This new technology brings significant benefits: ✅ Clearly identifies tumours in real time ✅ Enhances confidence in treatment accuracy ✅ Provides personalised radiotherapy plans daily ✅ Offers new hopes for complex cancer treatments GenesisCare continues to be at the forefront of cancer treatment with 2,500 patients already benefiting from this innovative tech. Patients in the North of England and Scotland will now find it easier to access these state-of-the-art treatments without the need to travel far. Read the full article below 👇 #healthcare #cancertreatment #innovation #cancerservices #NHS #privatehealthcare

An insightful article about the latest advancements in radiotherapy at GenesisCare UK. 🌟 Dr Peter Dickinson shared exciting news at ASTRO 2025 about adding the first Elekta Unity MR Linac to their fleet in Leeds. This new technology brings significant benefits: ✅ Clearly identifies tumours in real time ✅ Enhances confidence in treatment accuracy ✅ Provides personalised radiotherapy plans daily ✅ Offers new hopes for complex cancer treatments GenesisCare continues to be at the forefront of cancer treatment with 2,500 patients already benefiting from this innovative tech. Patients in the North of England and Scotland will now find it easier to access these state-of-the-art treatments without the need to travel far. Read the full article below 👇 #healthcare #cancertreatment #innovation #cancerservices #NHS #privatehealthcare

 NIHR (National Institute for Health and Care Research)                                    Radiotherapy after mastectomy can be avoided   Women with early-stage breast cancer can avoid radiotherapy after mastectomy as it does not affect long-term survival, new research finds.   An international trial found that patients with early-stage breast cancer who underwent a mastectomy (breast removal) and were taking anti-cancer drugs had similar 10-year survival rates, whether or not they received radiotherapy.    Experts say the findings should help guide treatment discussions, as many patients may not actually need radiotherapy.    The trial was funded by a Medical Research Council (MRC) and NIHR partnership. A team at the University of Edinburgh led the study. The results published in the New England Journal of Medicine.   https://lnkd.in/e22jEsk5

The Dutch Indication Protocol for Proton Radiotherapy of Esophageal Cancer has now been published in Radiotherapy & Oncology! Using a model-based selection approach, this protocol helps identify patients who are expected to gain a clinically relevant benefit from proton radiotherapy — supporting more personalized and evidence-based treatment decisions for esophageal cancer. This publication marks an important step forward in advancing precision radiotherapy and improving patient outcomes through smarter selection. 📄 Read the full article here: https://lnkd.in/ebTQN2Ap A big thank you to all collaborators and contributors who made this work possible! #ProtonTherapy #RadiationOncology #EsophagealCancer #PrecisionMedicine #ClinicalResearch #Innovation #RadiotherapyAndOncology #GreenJournal

Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications. Louis Potters https://lnkd.in/eBUnwsge #radonc #cancer #oncology

💡 When innovation meets evidence — radiotherapy’s future becomes value-based. Two complementary ESTRO–VBRO studies, just published in Radiotherapy & Oncology, define how innovation in radiotherapy should be assessed — not by hype, but by patient benefit and quality of evidence. 🔹 The Framework: establishes 4 innovation categories     – Drug-centred     – Radiation-centred     – Radiation-enabling     – Operational 🔹 The Data: analysis of 3,700 studies (2012–2022) reveals that fewer than 10% were randomised, with major differences in study design and endpoints. 🌍 For South-East Europe, the VBRO model offers a powerful roadmap to align adoption, reimbursement, and access to radiotherapy innovations with true value and evidence. 📘 Read the studies: ▪ Vandemaele M et al. Building an appraisal framework for radiotherapy innovations in a value-based context: The ESTRO-Value-based radiation oncology categorisation system. Radiother Oncol. 2025 Oct 4;213:111167. Link 👉🏻 https://lnkd.in/dB7AnsFt ▪ Vandemaele M et al. Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature. Radiother Oncol. 2025 Oct 4;213:111165. Link 👉🏻 https://lnkd.in/du8JxeBR Ajay Aggarwal Yolande Lievens Miet Vandemaele Pierre Blanchard European Society for Radiotherapy and Oncology (ESTRO) #RISINGRO #VBRO #ESTRO #ValueBasedOncology #Radiotherapy #CancerPolicy #SouthEastEurope #InnovationInOncology

The new ESTRO-VBRO framework highlights the importance of evidence-driven innovation in radiotherapy. RISING-RO supports this vision and seeks to adapt it to the realities of South-East Europe.